USA – LatchBio, a San Francisco, CA-based provider of a biotech research platform, raised $28 million in Series A funding.
The round was co-led by Coatue and existing investor Lux Capital with participation from Hummingbird Ventures, Caffeinated Capital, and existing investors Haystack and Fifty Years. Led by Alfredo Andere, co-founder and CEO, LatchBio provides a web-based platform that enables researchers to store and analyze data without touching code or cloud infrastructure. Using any browser, researchers can quickly import files from existing data stacks and access dozens of popular bioinformatics pipelines and data visualization tools including RNA-Seq, CRISPResso2 and AlphaFold. Scientists at leading industry organizations including the Innovative Genomics Institute (IGI), BitBio and Eligo Bioscience are leveraging the LatchBio platform to advance their work.03/06/2022
